- Target Audience
- Overall Learning Objectives
- Faculty
- Physician Continuing Medical Education
- Pharmacist Continuing Education
- Nursing Continuing Education
- Disclosure of Conflicts of Interest
- Disclosure of Unlabeled Use
- 1. Epidemiology and the Spread of HIV
- 2. The Origin, Evolution, and Epidemiology of HIV-1 and HIV-2
- 3. Mechanisms of HIV Transmission
- 4. HIV Transmission Prevention
- 5. Immunology
- 6. HIV Cure Strategies<sup>a</sup>
- 7. HIV Testing and Counseling
- 8. Laboratory Testing Strategies
- 9. The Medical History and Physical Examination of the HIV-Infected Patient
- 10. Initial Laboratory Evaluation and Risk Stratification of the HIV-Infected Patient
- 11. Clinical Syndromes and Differential Diagnosis in the HIV-Infected Patient
- 12. Health Maintenance
- 13. Issues in Specific Patient Populations
- 14. Complementary and Alternative Medicine/Integrative Medicine Approaches
- 15. Care Coordination
- 16. Palliative Care and End-of-Life Support
- 17. HIV Virology
- 18. Principles of Applied Clinical Pharmacokinetics and Pharmacodynamics in Antiretroviral Therapy
- 19. Classes of Antiretrovirals
- 20. Initiation of Antiretroviral Therapy
- 21. HIV-1 Resistance to Antiretroviral Drugs
- 22. Managing the Patient with Multidrug-Resistant HIV
- 23. Future Antiretrovirals, Immune-Based Strategies, and Therapeutic Vaccines
- 24. The Pharmacist’s Role in Caring for HIV-Positive Individuals
- 25. Solid Organ Transplantation in HIV-Infected Individuals
- 26. Antiretroviral Therapy in Pregnant Women
- 27. Antiretroviral Therapy in Children and Newborns
- 28. Immunosuppressants and Antiretroviral Therapy in HIV-Positive Transplant Patients
- 29. Understanding and Managing Antineoplastic and Antiretroviral Therapy
- 30. Substance Abuse in HIV Populations
- 31. Understanding the Use of Antiretroviral Drugs in the Aging Patient
- 32. Opportunistic Infections
- 33. Malignant Diseases in HIV
- 34. Dermatologic Complications
- 35. Endocrine Disorders
- 36. Non-opportunistic Infections
- 37. Psychiatric Illness and Treatment in HIV Populations
- 38. HIV-Associated Neurocognitive Disorders
- 39. HIV/Hepatitis Co-infection
- 40. Ocular Complications
- 41. Cardiovascular Disease
- 42. Renal Complications
- 43. Musculoskeletal Complications of HIV
- 44. Sexually Transmitted Diseases
- 45. HIV and Bone Health
- 46. HIV-Associated Lipodystrophy and Lipoatrophy
- 47. Dyslipidemia
- 48. Immune Reconstitution Inflammatory Syndrome
- 49. US Health Care Systems, HIV Programs, and Coverage Policy Issues
- 50. Legal Issues<sup>a</sup>
- 51. Research Design and Analysis
- 52. Ethical Conduct of Clinical Trials, Institutional Review Boards, Informed Consent, and Financial Conflicts of Interest
- Index
(p. 171) Complementary and Alternative Medicine/Integrative Medicine Approaches
- Chapter:
- (p. 171) Complementary and Alternative Medicine/Integrative Medicine Approaches
- Author(s):
Kalpana D. Shere-Wolfe
- DOI:
- 10.1093/med/9780190493097.003.0014
Complementary and alternative medicine (CAM) is a group of diverse medical and health care systems, practices, and products that are not currently considered part of conventional medicine. If a non-mainstream practice is used together with conventional medicine, it is considered “complementary.” If a non-mainstream practice is used in place of conventional medicine, it is considered “alternative.” Many patients use CAM approaches to their care. Often, patients do not disclose what methods they are using, and providers may have little knowledge of the effects of alternative medications. Interactions with antiretroviral therapy and other medications are important to the care of the patient. Physicians need to routinely ask about CAM use, particularly herbal medicines and supplements.
Access to the complete content on Oxford Medicine Online requires a subscription or purchase. Public users are able to search the site and view the abstracts for each book and chapter without a subscription.
Please subscribe or login to access full text content.
If you have purchased a print title that contains an access token, please see the token for information about how to register your code.
For questions on access or troubleshooting, please check our FAQs, and if you can't find the answer there, please contact us.
- Target Audience
- Overall Learning Objectives
- Faculty
- Physician Continuing Medical Education
- Pharmacist Continuing Education
- Nursing Continuing Education
- Disclosure of Conflicts of Interest
- Disclosure of Unlabeled Use
- 1. Epidemiology and the Spread of HIV
- 2. The Origin, Evolution, and Epidemiology of HIV-1 and HIV-2
- 3. Mechanisms of HIV Transmission
- 4. HIV Transmission Prevention
- 5. Immunology
- 6. HIV Cure Strategies<sup>a</sup>
- 7. HIV Testing and Counseling
- 8. Laboratory Testing Strategies
- 9. The Medical History and Physical Examination of the HIV-Infected Patient
- 10. Initial Laboratory Evaluation and Risk Stratification of the HIV-Infected Patient
- 11. Clinical Syndromes and Differential Diagnosis in the HIV-Infected Patient
- 12. Health Maintenance
- 13. Issues in Specific Patient Populations
- 14. Complementary and Alternative Medicine/Integrative Medicine Approaches
- 15. Care Coordination
- 16. Palliative Care and End-of-Life Support
- 17. HIV Virology
- 18. Principles of Applied Clinical Pharmacokinetics and Pharmacodynamics in Antiretroviral Therapy
- 19. Classes of Antiretrovirals
- 20. Initiation of Antiretroviral Therapy
- 21. HIV-1 Resistance to Antiretroviral Drugs
- 22. Managing the Patient with Multidrug-Resistant HIV
- 23. Future Antiretrovirals, Immune-Based Strategies, and Therapeutic Vaccines
- 24. The Pharmacist’s Role in Caring for HIV-Positive Individuals
- 25. Solid Organ Transplantation in HIV-Infected Individuals
- 26. Antiretroviral Therapy in Pregnant Women
- 27. Antiretroviral Therapy in Children and Newborns
- 28. Immunosuppressants and Antiretroviral Therapy in HIV-Positive Transplant Patients
- 29. Understanding and Managing Antineoplastic and Antiretroviral Therapy
- 30. Substance Abuse in HIV Populations
- 31. Understanding the Use of Antiretroviral Drugs in the Aging Patient
- 32. Opportunistic Infections
- 33. Malignant Diseases in HIV
- 34. Dermatologic Complications
- 35. Endocrine Disorders
- 36. Non-opportunistic Infections
- 37. Psychiatric Illness and Treatment in HIV Populations
- 38. HIV-Associated Neurocognitive Disorders
- 39. HIV/Hepatitis Co-infection
- 40. Ocular Complications
- 41. Cardiovascular Disease
- 42. Renal Complications
- 43. Musculoskeletal Complications of HIV
- 44. Sexually Transmitted Diseases
- 45. HIV and Bone Health
- 46. HIV-Associated Lipodystrophy and Lipoatrophy
- 47. Dyslipidemia
- 48. Immune Reconstitution Inflammatory Syndrome
- 49. US Health Care Systems, HIV Programs, and Coverage Policy Issues
- 50. Legal Issues<sup>a</sup>
- 51. Research Design and Analysis
- 52. Ethical Conduct of Clinical Trials, Institutional Review Boards, Informed Consent, and Financial Conflicts of Interest
- Index